Please try another search
Symbol | Exchange | Currency | ||
---|---|---|---|---|
ZELA | Copenhagen | DKK | Real-time | |
0NZU | London | DKK | Real-time |
Zealand Pharma A/S reported earnings results for the first quarter ended March 31, 2024. For the first quarter, the company reported sales was DKK 15.09 million compared to DKK 13.63 million a year ago. Net loss was DKK 228.65 million compared to DKK 193.63 million a year ago. Basic loss per share from continuing operations was DKK 3.71 compared to DKK 3.76 a year ago.
Period Ending: | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 |
---|---|---|---|---|
Total Revenue | 23.24 | 295.52 | ||
Gross Profit | -4.51 | 291.82 | 15.61 | |
Operating Income | -242.43 | 45.23 | ||
Net Income | -264.75 | 74.14 |
Period Ending: | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 |
---|---|---|---|---|
Total Assets | 3586.8 | 1979.99 | 2175.5 | |
Total Liabilities | 387.15 | 358.71 | ||
Total Equity | 1592.84 | 1816.8 |
Period Ending: | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 |
---|---|---|---|---|
Period Length: | 0 Months | 0 Months | 0 Months | 0 Months |
Cash From Operating Activities | -223.68 | 59.52 | -112.7 | |
Cash From Investing Activities | -1378.47 | 6.7 | 160.16 | |
Cash From Financing Activities | 1821.61 | 5.6 | 4.03 | |
Net Change in Cash | 223.08 | 64.87 | 56.76 |
Unlock access to over 1000 metrics with InvestingPro
View advanced insights on financial statements, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review